Latent-Y: The Autonomous AI Agent for Drug Design at Scale

Latent Labs has introduced Latent-Y, an AI agent that can create therapeutic antibodies quickly from text prompts. This technology uses Latent-X2, the company's advanced model for antibody and peptide design, to accelerate the process significantly. By leveraging Latent-Y, researchers can now achieve in hours what would typically take weeks with expert input. This innovation enables structural drug design without needing specialized infrastructure, broadening access for all researchers. Latent Labs is partnering with selected organizations to provide access to Latent-Y, which promises to revolutionize drug discovery.